The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis
Open Access
- 8 May 2018
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2018, 1-15
Abstract
Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), represent a family of RNA molecules that do not translate into protein. Nevertheless, they have the ability to regulate gene expression and play an essential role in immune cell differentiation and function. MicroRNAs were found to be differentially expressed in various tissues, and changes in their expression have been associated with several pathological processes. Yet, their roles in systemic lupus erythematosus (SLE) and lupus nephritis (LN) remain to be elucidated. Both SLE and LN are characterized by a complex dysfunction of the innate and adaptive immunity. Recently, significant findings have been made in understanding SLE through the use of genetic variant identification and expression pattern analysis and mouse models, as well as epigenetic analyses. Abnormalities in immune cell responses, cytokine and chemokine production, cell activation, and apoptosis have been linked to a unique expression pattern of a number of miRNAs that have been implicated in the immune pathogenesis of this autoimmune disease. The recent evidence that significantly increased the understanding of the pathogenesis of SLE drives a renewed interest in efficient therapy targets. This review aims at providing an overview of the current state of research on the expression and role of miRNAs in the immune pathogenesis of SLE and LN.Keywords
Funding Information
- Dr. Werner Jackstädt-Stiftung
This publication has 183 references indexed in Scilit:
- Circulating MicroRNA Expression Profiles Associated With Systemic Lupus ErythematosusArthritis & Rheumatism, 2013
- Identification of microRNA‐31 as a novel regulator contributing to impaired interleukin‐2 production in T cells from patients with systemic lupus erythematosusArthritis & Rheumatism, 2012
- Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus miceEMBO Molecular Medicine, 2011
- MicroRNAs Prevent the Generation of Autoreactive AntibodiesImmunity, 2010
- MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1Immunity, 2010
- CD8+ Tregs in lupus, autoimmunity, and beyondAutoimmunity Reviews, 2010
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh TranslocationImmunity, 2008
- MicroRNA-155 Is a Negative Regulator of Activation-Induced Cytidine DeaminaseImmunity, 2008
- Clinical and serological features of patients with autoantibodies to GW/P bodiesClinical Immunology, 2007
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004